Vcanbio Cell & Gene Engineering Corp

Vcanbio Cell & Gene Engineering Corp P/TBV

The Price to Tangible Book Value (P/TBV) of Vcanbio Cell & Gene Engineering Corp (600645.SS) as of Oct 15, 2026 is 3.89. In the previous year, Price to Tangible Book Value (P/TBV) was 4.27 — a change of -9.00% (lower).

P/TBV

3.89

YoY

-9.00%

Last updated:

Price to Tangible Book Value (P/TBV) of Vcanbio Cell & Gene Engineering Corp is 2025 3.89 . Price to Tangible Book Value (P/TBV) of Vcanbio Cell & Gene Engineering Corp was 2024 4.27 . It decreases by -9.00% lower compared to the previous year.

The Vcanbio Cell & Gene Engineering Corp P/TBV history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/TBV
Date
P/TBV
Jan 1, 2018
7.64 CNY
Jan 1, 2019
5.29 CNY
Jan 1, 2020
4.60 CNY
Jan 1, 2021
4.47 CNY
Jan 1, 2022
4.30 CNY
Jan 1, 2023
4.12 CNY
Jan 1, 2024
4.27 CNY
Jan 1, 2025
3.89 CNY
The Vcanbio Cell & Gene Engineering Corp P/TBV history
YEARP/TBVYoY
3.89-9.00%
4.27+3.70%
4.12-4.22%
4.30-3.80%
4.47-2.71%
4.60-13.01%
5.29-30.85%
7.64-51.27%
15.69+17.36%
13.37+0.07%
13.36-55.50%
30.01—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Vcanbio Cell & Gene Engineering Corp Stock analysis

What does Vcanbio Cell & Gene Engineering Corp do? Vcanbio Cell & Gene Engineering Corp Ltd is a biotechnology company based in Tianjin, China, operating within the healthcare sector. The company has been publicly traded since its IPO on May 4, 1993, and is listed under the ticker 600645.SS with ISIN CNE000000545. It employs 2,332 full-time staff and focuses on the development of life sciences technology. Vcanbio engages in cell culture, gene detection, and storage services, as well as the production and sale of cytokines culture solutions, cosmetics, and detection reagents. The company primarily serves domestic markets in China, with its headquarters located in Tianjin. Its website is http://www.vcanbio.com. The firm's business activities include the development and application of biotechnology solutions, though specific details on product names, acquisitions, or additional financial figures are not provided in the available information. Vcanbio operates as a public company with a presence in the Chinese biotechnology industry, emphasizing innovation in cell and gene engineering. Vcanbio Cell & Gene Engineering Corp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vcanbio Cell & Gene Engineering Corp stock

Price to Tangible Book Value (P/TBV) of Vcanbio Cell & Gene Engineering Corp is 3.89 in 2025.

Price to Tangible Book Value (P/TBV) of Vcanbio Cell & Gene Engineering Corp changed from 4.27 to 3.89, representing a -9.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Price to Tangible Book Value (P/TBV) Vcanbio Cell & Gene Engineering Corp since 2006 – with annual values, charts, and detailed analysis.

P/TBV compares the stock price to tangible book value per share, excluding goodwill and intangibles. It provides a conservative asset-based valuation.

To evaluate Price to Tangible Book Value (P/TBV)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Price to Tangible Book Value (P/TBV).

A 'good' varies by industry and company stage. On Eulerpool, you can compare Price to Tangible Book Value (P/TBV)'s Vcanbio Cell & Gene Engineering Corp with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Vcanbio Cell & Gene Engineering Corp

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Vcanbio Cell & Gene Engineering Corp